pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
  • phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›TERMINATEDphase readoutNCT04643535: In Vivo Glycocalyx as Predictor of Complications After Cardiac Surgery

    Sponsor: University Hospital, Rouen. Phase: . Conditions: Endothelial Dysfunction, Cardiovascular Diseases, Surgery

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT02961335: Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Diffuse Parenchymal Lung Diseases

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07528235: An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH

    Sponsor: Tang-Du Hospital. Phase: PHASE1. Conditions: Intracerebral Hemorrhage, Stroke-Associated Pneumonia (SAP)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07487935: Determinants of Clinical Outcome After Caudal Epidural Adhesiolysis for Chronic Lumbar Radicular Pain

    Sponsor: Mersin University. Phase: . Conditions: Radicular Pain, Adhesiolysis, Disc Disease Lumbar

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05855135: Assessment of Combined CCM and ICD Device in HFrEF

    Sponsor: Impulse Dynamics. Phase: NA. Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction, Implantable Defibrillator User, CCM Therapy, Non-ischemic Cardiomyopathy, Ischemic Cardiomyopathy, Sudden Cardiac Arrest, Arrhythmias, Cardiac, Ventricular Tachycardia, Ventricular Fibrillation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07563725: Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging)

    Sponsor: National Institute of Cardiology, Laranjeiras, Brazil. Phase: . Conditions: Aging Problems

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07620925: Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis: the Echo-AVCS Study

    Sponsor: Azienda Ospedaliera "Sant'Andrea". Phase: . Conditions: Aortic Stenosis, Chronic Coronary Syndrome, Calcific Aortic Valve Disease, Calcific Aortic Stenosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07596225: Effects of Kinect-Based Exergaming Versus Wii Fit Training on Balance and Fall Risk Among Healthy Older Adults

    Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Balance, Fall Risk

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07449390: Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole

    Sponsor: Acesion Pharma. Phase: PHASE1. Conditions: Healthy Participants

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07508774: Simulation and Feasibility Study of Drone-Delivered AED for Out-of-Hospital Cardiac Arrest

    Sponsor: Ye Sheng. Phase: NA. Conditions: Out-of-Hospital Cardiac Arrest (Simulated)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07515118: AI-TOP Study Artificial Intelligence for Trigger Optimization.

    Sponsor: Fundacion Dexeus. Phase: NA. Conditions: Infertility, Ovarian Stimulation, Artificial Intelligence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06750718: Innovative Rehabilitation: Integrating VR-Based Sensorimotor Training Into Comprehensive Neck Rehabilitation

    Sponsor: MTI University. Phase: NA. Conditions: Chronic Non Specific Neck Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00980460: Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

    Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma, PRETEXT III Hepatoblastoma, PRETEXT IV Hepatoblastoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05435820: Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder: A Study of Dosing With Laser

    Sponsor: Peruvian Clinical Research. Phase: NA. Conditions: Major Depressive Disorder, Depression Disorders

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06525623: Initial Resuscitation for Acute Kidney Injury in Cirrhosis

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Cirrhosis, Liver, Acute Kidney Injury, Hepatorenal Syndrome

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04832659: Assessment of Biomarkers in Children to Help Parents Quit Tobacco

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Tobacco Dependence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07129759: Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

    Sponsor: Lumos Pharma. Phase: PHASE3. Conditions: Growth Hormone Deficiency (GHD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06750380: Effects of Mackenzie and Tailored Mat Exercises in Post-Menopausal Women With Low Back Pain

    Sponsor: Riphah International University. Phase: NA. Conditions: Back Pain, Low

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07260279: Effect of an Educational Session for Abortive Women on Maternity Nurses' Practices

    Sponsor: Mansoura University. Phase: NA. Conditions: Abortion, Practice, Maternity

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03136679: Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease

    Sponsor: Baylor Research Institute. Phase: . Conditions: Mild Cognitive Impairment, Alzheimer Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07355062: A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

    Sponsor: Renibus Therapeutics, Inc.. Phase: PHASE3. Conditions: CKD, Metabolic Acidosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05953662: Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal Cancer

    Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: NA. Conditions: Colorectal Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06723262: Speech Perception of a Tonotopy-based Fitting for Cochlear Implant Recipients for 6 Months With Conventional Setting

    Sponsor: MED-EL Elektromedizinische Geräte GesmbH. Phase: NA. Conditions: Sensorineural Hearing Loss, Bilateral

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07575646: Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective Enamel Etching

    Sponsor: Cairo University. Phase: NA. Conditions: Cervical Caries

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07548346: MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

    Sponsor: Middle East North Africa Stroke and Interventional Neurotherapies Organization. Phase: NA. Conditions: Cerebral Venous Sinus Thrombosis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07405346: A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy

    Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: NA. Conditions: Advanced Leiomyosarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02782546: Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

    Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04870788: Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Advanced Malignant Solid Neoplasm

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07548788: A Lay Navigation Intervention for Patients With Lung Cancer

    Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Lung Cancer Non-Small Cell Cancer (NSCLC), Lung Cancer Small Cell Lung Cancer (SCLC), Patient Navigation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07657403: CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial

    Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: NA. Conditions: Brain Neoplasms, Eloquent Area Brain Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02689427: Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Triple-Negative Breast Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07493642: Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease

    Sponsor: Fu Jen Catholic University Hospital. Phase: NA. Conditions: Chronic Kidney Disease (CKD), CKD Stage 1-3

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04953273: A Case Management Algorithm for Women Victims of Violence

    Sponsor: University Hospital, Lille. Phase: NA. Conditions: Post-Traumatic Stress Disorder, Violence-Related Symptom

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07661173: A Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic ctDNA (MRD) Changes in Locally Advanced or Metastatic EGFR-mutated Non-small Cell Lung Cancer

    Sponsor: Anhui Provincial Cancer Hospital. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05503069: Community Interventions to Improve Breastfeeding

    Sponsor: University of Mississippi Medical Center. Phase: NA. Conditions: Breastfeeding, Breastfeeding, Exclusive

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03407469: Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

    Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Cancer-related Venous Thromboembolism

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07360483: Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery

    Sponsor: Cairo University. Phase: NA. Conditions: Hypertrophic Scars

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03229083: Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma

    Sponsor: University of Rochester. Phase: NA. Conditions: Advanced Renal Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06411054: The Efficacy of Acu-TENS as an Adjunct Analgesic During USG-MVA

    Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Pain, Acute

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05078905: Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: COVID-19, Vaccination, Healthy Volunteer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06456905: Automated Reinforcement Management Systems, Phase II

    Sponsor: Washington State University. Phase: NA. Conditions: Alcohol Use Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07444905: Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma

    Sponsor: Tongji Hospital. Phase: . Conditions: HCC - Hepatocellular Carcinoma, Machine Learning, Evaluation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07352605: Percutaneous Drainage Versus Antibiotic Therapy for Acute Diverticulitis With Abscess.

    Sponsor: Azienda Sanitaria di Firenze. Phase: NA. Conditions: Diverticular Disease of Colon

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07221266: Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

    Sponsor: University of Texas, El Paso. Phase: NA. Conditions: Parkinson Disease (PD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00455156: Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring

    Sponsor: Premier Research. Phase: PHASE3. Conditions: Contraception

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07511166: A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation

    Sponsor: Johnson & Johnson Medical (Shanghai) Ltd.. Phase: . Conditions: Atrial Fibrillation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05287256: Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC

    Sponsor: Johns Hopkins University. Phase: PHASE1. Conditions: Behavioral Pharmacology of Cannabis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05678322: Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

    Sponsor: NYU Langone Health. Phase: PHASE3. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07382622: Effect of JointIQ on Joint Discomfort in Healthy Subjects

    Sponsor: Chung Shan Medical University. Phase: NA. Conditions: Joint Discomfort

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07056322: Optimal Meals to Reduce Bone Resorption in Women With Osteopenia

    Sponsor: University of Aarhus. Phase: NA. Conditions: Osteopenia

    full page →ctgov ↗
    ← prev
    page 79 of 104
    next →